Mezzion Pharma메지온
140410 · KOSDAQ · ₩140410 · 메지온
₩51,200▼ ₩1,400 (2.66%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 29, 2026Open on DART
Predicted impact: Low
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 20, 2026Open on DART
Predicted impact: Low
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 2, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 28, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 21, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 30, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)May 22, 2026Open on DART
- Material Matters Report (Decision on Acquisition of Own Convertible Bonds Before Maturity)주요사항보고서(자기전환사채만기전취득결정)May 22, 2026Open on DART
- Lawsuit filed or ruled소송등의제기ㆍ신청(일정금액이상의청구)May 21, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (6th Series CB)증권발행결과(자율공시) (제6회차 CB)May 12, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Apr 30, 2026Open on DART
- Lawsuit filed or ruled소송등의판결ㆍ결정(일정금액이상의청구)Apr 17, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 30, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 18, 2026Open on DART
- Audit report submitted감사보고서제출Mar 16, 2026Open on DART
- Occurrence of Derivatives Trading Loss파생상품거래손실발생Mar 16, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 13, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 13, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 13, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Feb 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 6, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Feb 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Feb 2, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Dec 15, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Lawsuit filed or ruled소송등의제기ㆍ신청(일정금액이상의청구)Oct 14, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Oct 14, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Oct 10, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Sep 30, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Sep 17, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 13, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 8, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 20, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 20, 2025Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Jun 13, 2025Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Jun 13, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jun 10, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jun 10, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 5, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Mezzion Pharma / 메지온 / 140410 / KRX:140410
Source: KRX statistical information